Lipocine's PPD Phase 3 Study (LPCN 1154) Hits 80% Enrollment Milestone
Tremonton
Archived
•
December 16, 2025
•
Second Drug Safety Monitoring Board (DSMB) meeting update planned for mid-January 2026Topline results on track for the second quarter of 2026
Source: https://www.tremontonleader.com/search/?f=rss&t=article&l=50&c=news* - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



